DRE IG 14 01 Session.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

DRE IG 14 01 Session.Pdf Session 14 - Hallucinogens Session 14 - Hallucinogens Learning Objectives Learning Objectives • Explain a brief history of the • Describe the typical time parameters, Hallucinogen category of drugs i.e. onset and duration of effects • Identify common drug names and associated with this category terms associated with this category • List the clues that are likely to emerge • Identify common methods of when the drug influence evaluation is administration for this category conducted for a person under the • Describe the symptoms, observable influence of this category of drugs signs and other effects associated with • Correctly answer the “topics for study” this category questions at the end of this session Drug Recognition Expert Course 14-2 Drug Recognition Expert Course 14-3 Briefly review the objectives, content and activities of this session. Upon successfully completing this session the participant will be able to: • Explain a brief history of the Hallucinogen category of drugs • Identify common drug names and terms associated with this category • Identify common methods of administration for this category • Describe the symptoms, observable signs and other effects associated with this category • Describe typical time parameters, i.e. onset and duration of effects, associated with this category • List the clues that are likely to emerge when the drug influence evaluation is conducted for a person under the influence of this category of drugs • Correctly answer the “topics for study” questions at the end of this session CONTENT SEGMENTS ..................................................................................... LEARNING ACTIVITIES A. Overview of the Category ............................................................. Instructor-Led Presentations B. Possible Effects .......................................................................... Review of Drug Evaluation and ..................................................................................................................... Classification Exemplars C. Onset and Duration Effects ....................................................................... Reading Assignments D. Overdose Signs and Symptoms ................................................................... Video Presentations E. Expected Results of the Evaluation ............................................................. Slide Presentations F. Classification Exemplars Revised: Drug Recognition Expert Course Session 14 10/2015 Hallucinogens Page 1 of 24 Session 14 - Hallucinogens Hallucinogens - Overview Hallucinogens are drugs that affect a person’s perceptions, sensations, thinking, self awareness and emotions Drug Recognition Expert Course 14-4 A. Overview of the Category Hallucinogens are drugs that affect a person’s perceptions, sensations, thinking, self- awareness and emotions. The word “Hallucinogen” means something that causes hallucinations. Definition from The Random House College Dictionary (Revised Edition, 1980) A hallucination is a sensory experience of something that does not exist outside the mind. Seeing, hearing, smelling, tasting or feeling something that isn’t really there. Having distorted sensory perceptions, so that things look, sound, smell, etc. differently than they really are. Hallucinogenic drugs usually produce what are called pseudo-hallucinations: i.e. the user typically is aware that what he or she is seeing, hearing, smelling, etc. isn’t real, but is a product of the drug. But emphasize that the fact that the user knows the hallucinations aren’t real doesn’t make those hallucinations any less dangerous if they occur while driving. Revised: Drug Recognition Expert Course Session 14 10/2015 Hallucinogens Page 2 of 24 Session 14 - Hallucinogens Synesthesia A transposition of senses • “Seeing sounds” • “Hearing colors” Drug Recognition Expert Course 14-5 Synesthesia One common type of hallucination produced by these drugs is called Synesthesia, which is a sensory perception disorder, in which an input via one sense is perceived by the brain as an input via another sense. In its simplest terms, it is a transposition of senses. Synesthesia can occur naturally in a small percentage of the population, and can differ from drug induced synesthesia. Examples: The user may “see a flash of color, or some other sight, when the telephone rings.” • Sounds for example, may be transposed into sights. • Sights may be transposed into odors. • The user may “smell” a particular fragrance when he or she looks at something painted yellow. • The illusions and distorted perceptions produced by hallucinogenic drugs may be very alarming, even terrifying. • They may produce panic and uncontrolled excitement. Point out that the expression “bad trip” refers principally to these panic filled reactions to Hallucinogens. The user may be unable to cope with the terror, and may attempt to flee wildly. A user who is emotionally or mentally unstable may become psychotic in response to this frightening experience. Revised: Drug Recognition Expert Course Session 14 10/2015 Hallucinogens Page 3 of 24 Session 14 - Hallucinogens “Flashback” A vivid recollection of a hallucinogenic experience Drug Recognition Expert Course 14-6 Flashback A terrifying “bad trip” sometimes may be re-experienced as a flashback. In simple terms, a flashback is a vivid recollection of a portion of a hallucinogenic experience. A flashback does not occur because of a residual quantity of drug in the user’s body. Instead, a flashback essentially is a very intense daydream. But point out that subsequent use of the drug may precipitate a flashback, by causing the user to re-experience the frightening illusions of the previous “bad trip.” Revised: Drug Recognition Expert Course Session 14 10/2015 Hallucinogens Page 4 of 24 Session 14 - Hallucinogens Session 14 - Hallucinogens 3 Types of Flashbacks Sensory Perceptions Emotional • Most dangerous - feelings of panic, fear, etc., Delusion sensation of “bad trip” • A false belief Somatic • Altered body sensations, tremors, weakness, dizziness, crawly, tingly feeling on the skin Illusion Perceptual • Distortions of vision, hearing, smell, taste and • A false perception touch (associated with original “trip” least harmful, unless driving a motor vehicle) Drug Recognition Expert Course 14-7 Drug Recognition Expert Course 14-8 Types of Flashbacks There are three types of flashback: • Emotional: most dangerous - feelings of panic, fear, etc; the sensations of a “bad trip.” • Somatic: Altered body sensations, tremors, weakness, dizziness, crawly, tingly feelings on the skin. • Perceptual: Distortions of vision, hearing, smell, taste and touch (associated with original “trip” least harmful, unless driving a motor vehicle) Delusion and Illusion Remember that hallucinogens produce delusions, illusions, or both. • A delusion is a false belief. Example of a delusion: “I am an Elephant.” • An illusion is a false perception, i.e. a misrepresentation of what the senses are receiving. Example of an illusion: “I see an Elephant.” Revised: Drug Recognition Expert Course Session 14 10/2015 Hallucinogens Page 5 of 24 Session 14 - Hallucinogens Psychotomimetic “Psychotomimetic” means “something that mimics psychosis.” A psychosis is a major mental disorder. It implies a loss of touch with reality. Drug Recognition Expert Course 14-9 Because they often make the user appear to be psychotic, Hallucinogens are sometimes called psychotomimetic drugs. “Psychotomimetic” means “something that mimics psychosis.” A psychosis is a major mental disorder. It implies a loss of touch with reality. Point out some Hallucinogens may create a psychotomimetic response in the user, meaning that they literally appear to have psychosis. Some Hallucinogens come from natural sources, while others are synthetically manufactured. For your information: Other naturally occurring Hallucinogens include nutmeg, jimson weed, morning glory seeds, salvia divinorum, and bufotenine, a substance found in the glands of certain toads. Some regional or local Hallucinogens may be discussed in more detail. Peyote, Psilocybin and Salvia Divinorum are examples of naturally occurring Hallucinogens. Revised: Drug Recognition Expert Course Session 14 10/2015 Hallucinogens Page 6 of 24 LSD, TMA, DMT, MDMA, MDA, and 2CB are examples of synthetically manufactured Hallucinogens. For your information: Drugs such as MDA, MDMA, STP, and TMA all contain amphetamine based compounds. They are for this reason sometimes called “psychedelic amphetamines.” In essence, they are high powered CNS Stimulants that cause hallucinations. • LSD: Lysergic Acid Diethylamide. • 25I-NBOMe: 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine. This synthetic drug and analogs exhibit effects similar to LSD. Referred to as “N-Bomb” or “Smiles”. As of late 2013, 25I-NBOMe and analogs have been banned by DEA for a minimum of two years. • TMA: Trimethoxyamphetamine • DMT: Dimethyltryptamine • MDMA is an abbreviation for 3,4-Methylenedioxymethamphetamine and is commonly referred to as “Ecstasy.” It is a hallucinogen that also acts as a stimulant. It produces an energizing effect, as well as distortions in time and perception and enhances enjoyment from tactile experiences. • MDA is an abbreviation for 3,4-Methylenedioxyamphetamine. It is normally produced as a clear liquid, or as a white powder in capsule or tablet form. • 2CB (4-Bromo-2, 5-Dimethoxyphenethylamine) is a white powder usually found in pressed tablets or gel caps. It is considered a synthetic psychedelic
Recommended publications
  • The Ethics of Psychedelic Medicine: a Case for the Reclassification of Psilocybin for Therapeutic Purposes
    THE ETHICS OF PSYCHEDELIC MEDICINE: A CASE FOR THE RECLASSIFICATION OF PSILOCYBIN FOR THERAPEUTIC PURPOSES By Akansh Hans A thesis submitted to Johns Hopkins University in conformity with the requirements for the degree of Master of Bioethics Baltimore, Maryland May 2021 © 2021 Akansh Hans All Rights Reserved I. Abstract Our current therapeutic mental health paradigms have been unable to adequately handle the mental illness crisis we are facing. We ought to ‘use every tool in our toolbox’ to help individuals heal, and the tool we should be utilizing right now is Psilocybin. Although it is classified as a Schedule I drug, meaning that it is believed to have a high potential for abuse, no accepted medical uses, and a lack of safety when used under medical supervision, Psilocybin is not addictive and does not have a high potential for abuse when used safely under medical supervision. For these reasons alone, Psilocybin deserves a reclassification for therapeutic purposes. However, many individuals oppose Psilocybin-assisted psychotherapy on ethical grounds or due to societal concerns. These concerns include: a potential change in personal identity, a potential loss of human autonomy, issues of informed consent, safety, implications of potential increased recreational use, and distributive justice and fairness issues. Decriminalization, which is distinct from reclassification, means that individuals should not be incarcerated for the use of such plant medicines. This must happen first to stop racial and societal injustices from continuing as there are no inherently ‘good’ or ‘bad’ drugs. Rather, these substances are simply chemicals that humans have developed relationships with. As is shown in this thesis, the ethical implications and risks of psychedelic medicine can be adequately addressed and balanced, and the benefits of Psilocybin as a healing tool far outweigh the risks.
    [Show full text]
  • Hallucinogens
    Hallucinogens What Are Hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and others are synthetic (human-made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes. Hallucinogens are a Types of Hallucinogens diverse group of drugs Classic Hallucinogens that alter perception, LSD (D-lysergic acid diethylamide) is one of the most powerful mind- thoughts, and feelings. altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other Hallucinogens are split grains. into two categories: Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) comes from certain classic hallucinogens and types of mushrooms found in tropical and subtropical regions of South dissociative drugs. America, Mexico, and the United States. Peyote (mescaline) is a small, spineless cactus with mescaline as its main People use hallucinogens ingredient. Peyote can also be synthetic. in a wide variety of ways DMT (N,N-dimethyltryptamine) is a powerful chemical found naturally in some Amazonian plants. People can also make DMT in a lab.
    [Show full text]
  • Adverse Reactions to Hallucinogenic Drugs. 1Rnstttutton National Test
    DOCUMENT RESUME ED 034 696 SE 007 743 AUTROP Meyer, Roger E. , Fd. TITLE Adverse Reactions to Hallucinogenic Drugs. 1rNSTTTUTTON National Test. of Mental Health (DHEW), Bethesda, Md. PUB DATP Sep 67 NOTE 118p.; Conference held at the National Institute of Mental Health, Chevy Chase, Maryland, September 29, 1967 AVATLABLE FROM Superintendent of Documents, Government Printing Office, Washington, D. C. 20402 ($1.25). FDPS PRICE FDPS Price MFc0.50 HC Not Available from EDRS. DESCPTPTOPS Conference Reports, *Drug Abuse, Health Education, *Lysergic Acid Diethylamide, *Medical Research, *Mental Health IDENTIFIEPS Hallucinogenic Drugs ABSTPACT This reports a conference of psychologists, psychiatrists, geneticists and others concerned with the biological and psychological effects of lysergic acid diethylamide and other hallucinogenic drugs. Clinical data are presented on adverse drug reactions. The difficulty of determining the causes of adverse reactions is discussed, as are different methods of therapy. Data are also presented on the psychological and physiolcgical effects of L.S.D. given as a treatment under controlled medical conditions. Possible genetic effects of L.S.D. and other drugs are discussed on the basis of data from laboratory animals and humans. Also discussed are needs for futher research. The necessity to aviod scare techniques in disseminating information about drugs is emphasized. An aprentlix includes seven background papers reprinted from professional journals, and a bibliography of current articles on the possible genetic effects of drugs. (EB) National Clearinghouse for Mental Health Information VA-w. Alb alb !bAm I.S. MOMS Of NAM MON tMAN IONE Of NMI 105 NUNN NU IN WINES UAWAS RCM NIN 01 NUN N ONMININI 01011110 0.
    [Show full text]
  • DEMAND REDUCTION a Glossary of Terms
    UNITED NATIONS PUBLICATION Sales No. E.00.XI.9 ISBN: 92-1-148129-5 ACKNOWLEDGEMENTS This document was prepared by the: United Nations International Drug Control Programme (UNDCP), Vienna, Austria, in consultation with the Commonwealth of Health and Aged Care, Australia, and the informal international reference group. ii Contents Page Foreword . xi Demand reduction: A glossary of terms . 1 Abstinence . 1 Abuse . 1 Abuse liability . 2 Action research . 2 Addiction, addict . 2 Administration (method of) . 3 Adverse drug reaction . 4 Advice services . 4 Advocacy . 4 Agonist . 4 AIDS . 5 Al-Anon . 5 Alcohol . 5 Alcoholics Anonymous (AA) . 6 Alternatives to drug use . 6 Amfetamine . 6 Amotivational syndrome . 6 Amphetamine . 6 Amyl nitrate . 8 Analgesic . 8 iii Page Antagonist . 8 Anti-anxiety drug . 8 Antidepressant . 8 Backloading . 9 Bad trip . 9 Barbiturate . 9 Benzodiazepine . 10 Blood-borne virus . 10 Brief intervention . 11 Buprenorphine . 11 Caffeine . 12 Cannabis . 12 Chasing . 13 Cocaine . 13 Coca leaves . 14 Coca paste . 14 Cold turkey . 14 Community empowerment . 15 Co-morbidity . 15 Comprehensive Multidisciplinary Outline of Future Activities in Drug Abuse Control (CMO) . 15 Controlled substance . 15 Counselling and psychotherapy . 16 Court diversion . 16 Crash . 16 Cross-dependence . 17 Cross-tolerance . 17 Custody diversion . 17 Dance drug . 18 Decriminalization or depenalization . 18 Demand . 18 iv Page Demand reduction . 19 Dependence, dependence syndrome . 19 Dependence liability . 20 Depressant . 20 Designer drug . 20 Detoxification . 20 Diacetylmorphine/Diamorphine . 21 Diuretic . 21 Drug . 21 Drug abuse . 22 Drug abuse-related harm . 22 Drug abuse-related problem . 22 Drug policy . 23 Drug seeking . 23 Drug substitution . 23 Drug testing . 24 Drug use .
    [Show full text]
  • Hallucinogens
    Hallucinogens What are hallucinogens? Hallucinogens are a diverse group of drugs that alter a person’s awareness of their surroundings as well as their own thoughts and feelings. They are commonly split into two categories: classic hallucinogens (such as LSD) and dissociative drugs (such as PCP). Both types of hallucinogens can cause hallucinations, or sensations and images that seem real though they are not. Additionally, dissociative drugs can cause users to feel out of control or disconnected from their body and environment. Some hallucinogens are extracted from plants or mushrooms, and some are synthetic (human- made). Historically, people have used hallucinogens for religious or healing rituals. More recently, people report using these drugs for social or recreational purposes, including to have fun, deal with stress, have spiritual experiences, or just to feel different. Common classic hallucinogens include the following: • LSD (D-lysergic acid diethylamide) is one of the most powerful mind-altering chemicals. It is a clear or white odorless material made from lysergic acid, which is found in a fungus that grows on rye and other grains. LSD has many other street names, including acid, blotter acid, dots, and mellow yellow. • Psilocybin (4-phosphoryloxy-N,N- dimethyltryptamine) comes from certain types of mushrooms found in tropical and subtropical regions of South America, Mexico, and the United States. Some common names for Blotter sheet of LSD-soaked paper squares that users psilocybin include little smoke, magic put in their mouths. mushrooms, and shrooms. Photo by © DEA • Peyote (mescaline) is a small, spineless cactus with mescaline as its main ingredient. Peyote can also be synthetic.
    [Show full text]
  • Hallucinogens Hallucinations
    Hallucinogens Hallucinations Affect a person’s: Perceptions Sensations Thinking Self-awareness Emotional state Synesthesia Transposition of senses: Seeing sounds Hearing colors Flash Back Vivid recollection of hallucinogenic experience Emotional “Bad trip” (Panic, fear, etc.) Somatic Altered body sensations, tremors, weakness, dizziness, crawly, tingling feeling on the skin Perceptual Distortions of the five senses Psychotomimetic Something that mimics psychosis Delusion A false belief Illusion A false perception Natural Hallucinogens Peyote (Mescaline) Psilocybin Natural Hallucinogens Jimson Weed Bufo Alvarius Natural Hallucinogens Morning Glory Seeds Nutmeg Natural Hallucinogens Salvia Divinorum Synthetic Hallucinogens LSD (Lysergic Acid Diethylamide) MDMA “Ecstasy” (3, 4 Methylenedioxymethamphetamine) Methods of Ingestion Orally Smoked Transdermal Insufflation Injection General Indicators Varies and influenced by personality, mood, expectations and surroundings of user Depressed = deeper depression Pleasant = heightened pleasure Can uncover emotional flaws Bad “trip” Effects Hallucinations Body tremors Paranoia Uncoordinated Nausea Disoriented Perspiring Memory loss Difficulty in speech Flashbacks Synesthesia Poor time perception Dazed appearance Onset and Duration - Peyote 30 minutes: Onset Nausea, elevated blood pressure, pulse and temperature and dilated pupils 60 minutes: Begin hallucinogenic effects Visual distortions, rich colors, changing forms and moving shapes 3-4 hours: Peak effects “Synesthesia”
    [Show full text]
  • Technology for Drug Testing
    If you have issues viewing or accessing this file, please contact us at NCJRS.gov. Aud,OTeleconlerence Packet Technology for Drug Testing November 17, 1998 2:30 - 4:00 p.m. (EST) F'ROr:'t::~"~ ~ '~ ,.jr: National Criminal Justice Releronce Service (~NOJ.R..~).,, ,~..~ ... Box 6000 .... "-- Rockville, ME) 20849 °6000i'~~ ............ Kevin Jackson Saralyn Borrowman Presenters Provided by the American Probation and Parole Association Funded by the Office of Juvenile Justice and Delinquency Prevention © ® Prepared under Award No. 98-JB-VX-0103 from the Office of Juvenile Justice and Delinquency Prevention, Office of Justice Programs, U. S. Department of Justice. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the U. S. Department of Justice. © TECHNOLOGY FOR DRUG TESTING Training Objectives As a result of this teleconference, participants will be able to: • Name six types of technology for substance abuse testing and describe the relative advantages and disadvantages of each. • Describe the difference between immunoassay and chromatography testing for urine. • List the classifications of substances that can be detected through urine testing and those for which tests are either unavailable or require more difficult or costly testing methods. • Identify ways that urine tests can be adulterated or otherwise tampered with and ways to detect and/or avoid these problems. • Make decisions for program policies and procedures regarding onsite or off site testing, instrument or noninstrument testing, drugs to test for, scheduled or random testing, frequency of testing, specimen collection procedures, chain of custody procedures, confirmation tests, cutoff levels; and • Specify how positive and negative results will be used ABOUT THE PRESENTERS Kevin Jackson Saralyn Borrowman National Institute of Justice Office of Science and Technology Washington, D.C.
    [Show full text]
  • Mental Health Effects of Recreational Drugs and Alcohol Understanding
    Understanding the mental health effects of recreational drugs and alcohol understanding mental health effects of recreational drugs and alcohol 1 Understanding the mental health effects of recreational drugs and alcohol This booklet is for anyone who wants to know more about the mental health effects of recreational drugs and alcohol. It explains how drugs and alcohol affect mental health, and what might happen if you use recreational drugs and have a mental health problem. It also provides information on what support is available and guidance for friends and family. Contents What are recreational drugs and alcohol? 4 How can recreational drugs affect mental health? 5 What types of drugs are there? 8 What effect could different drugs have? 11 Can recreational drugs and medication affect each other? 32 What support is available? 36 What help is available if I have a dual diagnosis? 38 How can family and friends help? 42 Useful contacts 45 3 Understanding the mental health effects of recreational drugs and alcohol What are recreational drugs and alcohol? Drugs are substances people take: • to give themselves a pleasurable experience • to help them feel better if they are having a bad time • because their friends are using them • to see what it feels like. They include alcohol, tobacco (nicotine), substances such as cannabis, heroin, cocaine and ecstasy, and some prescribed medicines. All my experiences with recreational drug use started due to social influences, of wanting to 'fit in'. Recreational drugs may be: • legal – such as nicotine and alcohol • illegal – this means it is against the law to have them or supply them to other people; most recreational drugs are illegal • controlled – these are drugs used in medicine, such as benzodiazepines; it is legal to take controlled drugs if a doctor has given you a prescription for them but it is illegal to have them if not; it is also illegal to give or sell controlled drugs to anyone else.
    [Show full text]
  • Downloaded 09/26/21 04:47 PM UTC Ona What, If Any, Extra-Pharmacological Factors Are Commonly SECTION 1 Related to the Adverse Reaction Known As a Bad Trip
    ORIGINAL ARTICLE Journal of Psychedelic Studies 2(1), pp. 53–60 (2018) DOI: 10.1556/2054.2018.001 First published online March 20, 2018 Inside bad trips: Exploring extra-pharmacological factors GENÍS ONA* Department of Anthropology, Rovira i Virgili University, Tarragona, Spain (Received: June 18, 2017; revised manuscript received: January 16, 2018; accepted: January 17, 2018) Objective: This study aimed to clarify the influence of extra-pharmacological factors in the etiology of bad trips,a common adverse reaction related to the consumption of psychedelic drugs. Methods: A descriptive approach was adopted. The information was collected using a web-based survey. The survey respondents volunteered to participate based on the condition that they had suffered a bad trip in the past. Results: This report reveals some variables that are commonly related to this adverse reaction (i.e., the recreational consumption of drugs, the consumption of drugs in large, open outdoor spaces, or being inexperienced with the drug). In addition, we note that some problems, which may be related to bad trips (i.e., mixing drugs, ignorance about the purity, or the dosage), can be solved through harm- reduction strategies. Conclusions: We found certain aspects that could be related to the appearance of a bad trip, but it is not possible to establish a causal connection. We recommend conducting prospective studies with larger samples to collect more information about the role of extra-pharmacological factors. Keywords: psychedelic, bad trip, drug, adverse reaction
    [Show full text]
  • Nbomes–Highly Potent and Toxic Alternatives of LSD
    fnins-14-00078 February 24, 2020 Time: 17:4 # 1 REVIEW published: 26 February 2020 doi: 10.3389/fnins.2020.00078 NBOMes–Highly Potent and Toxic Alternatives of LSD Jolanta B. Zawilska1*, Monika Kacela1 and Piotr Adamowicz2 1 Department of Pharmacodynamics, Medical University of Łód´z,Łód´z,Poland, 2 Department of Forensic Toxicology, Institute of Forensic Research, Kraków, Poland Recently, a new class of psychedelic compounds named NBOMe (or 25X-NBOMe) has appeared on the illegal drug market. NBOMes are analogs of the 2C family of phenethylamine drugs, originally synthesized by Alexander Shulgin, that contain a N-(2-methoxy)benzyl substituent. The most frequently reported drugs from this group are 25I-NBOMe, 25B-NBOMe, and 25C-NBOMe. NBOMe compounds are ultrapotent and highly efficacious agonists of serotonin 5-HT2A and 5-HT2C receptors (Ki values in low nanomolar range) with more than 1000-fold selectivity for 5-HT2A compared with 5-HT1A. They display higher affinity for 5-HT2A receptors than their 2C counterparts and have markedly lower affinity, potency, and efficacy at the 5- HT2B receptor compared to 5-HT2A or 5-HT2C. The drugs are sold as blotter papers, or in powder, liquid, or tablet form, and they are administered sublingually/buccally, intravenously, via nasal insufflations, or by smoking. Since their introduction in the early 2010s, numerous reports have been published on clinical intoxications and Edited by: Liana Fattore, fatalities resulting from the consumption of NBOMe compounds. Commonly observed Italian National Research Council, Italy adverse effects include visual and auditory hallucinations, confusion, anxiety, panic Reviewed by: and fear, agitation, uncontrollable violent behavior, seizures, excited delirium, and Adam Halberstadt, sympathomimetic signs such mydriasis, tachycardia, hypertension, hyperthermia, and University of California, San Diego, United States diaphoresis.
    [Show full text]
  • Health Risks Associated with the Use of Illicit Drugs and Alcohol
    HEALTH RISKS ASSOCIATED WITH THE USE OF ILLICIT DRUGS AND ALCOHOL The brief summaries are an overview of the major health risks associated with the use of illicit drugs and alcohol. Abuse of alcohol and other drugs can lead to chemical dependency and can be harmful during pregnancy. Alcohol—Did you know that • Alcohol is a depressant that decreases the responses of the central nervous system. • Excessive drinking can cause liver damage and psychotic behavior. • As little as two beers or drinks can impair coordination and thinking. • Alcohol is often used by substance abusers to enhance the effects of other drugs. • Alcohol continues to be the most frequently abused substance among young adults. What are the Dangers of Alcohol Abuse? Risk of injury or death as a result of accident or violence, impaired vision, impaired motor coordination, memory defects, hallucinations, blackouts, and seizures. Long-term use can result in permanent damage to the brain, elevated blood pressure and heart rate, risk of stroke, heart failure, respiratory depression and failure, pneumonia, tuberculosis, lung abscesses, increased risk of mouth and throat cancer, alcoholic fatty liver, hepatitis, and cirrhosis, duodenal ulcers, reflux, diarrhea, impaired judgment and verbal ability, apathy, introversion, antisocial behavior, inability to concentrate, and deterioration of relationships with family, friends, and co-workers. Alcohol is an especially dangerous drug for pregnant women. Drinking during pregnancy raises the risk of low-birth weight babies and intrauterine growth retardation, increasing the danger of infection, feeding difficulties, and long-term developmental problems. Marijuana—Also known as: Pot, Grass, Joints, Roaches, Reefer, Weed, Mary Jane—Did you know that • Marijuana may cause impaired short-term memory, a shortened attention span and delayed reflexes.
    [Show full text]
  • Appendix A: Drug and Alcohol-Free Workplace and College Premises
    Drug and Alcohol-Free Workplace and College Premises APPENDIX A P-2443, P-5621, P-6821, and P-9154 1 of 6 I. Pursuant to the Drug and Alcohol-Free Workplace and College Premises Policies, the following additional information is provided to Los Rios Community College District faculty, staff, and students about the use of alcohol and illegal drugs: Disciplinary Sanctions Violation of the Drug and Alcohol-Free Workplace and College Premises Policies shall result in the prompt imposition of sanctions. For faculty, administrators, or staff, these sanctions depend on the nature and severity of the offense and may range from a warning, a counseling memorandum, a written reprimand, required satisfactory participation in counseling or rehabilitation programs, probation, paid or unpaid suspension, termination of employment, and/or referral to proper law enforcement authorities for prosecution. For students, these sanctions also depend on the nature and severity of the offense and may range from a warning, a counseling memorandum, a written reprimand, required satisfactory participation in counseling or rehabilitation programs, probation, suspension, expulsion from the College, and/or referral to proper law enforcement authorities for prosecution. Any sanctions taken against faculty, administrators, or staff will be carried out in accordance with the applicable Collective Bargaining Agreement, the District’s Policies and Regulations, and the Education Code. Any sanctions taken against students will be carried out in accordance with the District’s Policies and Regulations and the Education Code. Education Counseling and Rehabilitation Programs The Employee Assistance Program (EAP) offers assessment, short-term counseling, and referral services for faculty, staff, and their dependents.
    [Show full text]